SCHEMBL22889144

SCHEMBL22889144

c1ccc(-c2ccc(-c3cc(-c4cccc5c4oc4ccccc45)nc(-c4ccc(-c5ccccc5)c5ccccc45)n3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.47
GGPS1 O95749 1/20 0.38
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PRKDC P78527 5/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CB P42338 1/20 0.37
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
MAPT P10636 5/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
NTSR1 P30989 1/20 0.36
ATM Q13315 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
ACACA Q13085 1/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
LMNA P02545 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22888685 0.94 ALOX5 (0.48) ALOX5GGPS1TSHRMAPK1HSD17B10
SCHEMBL16573899 0.94 ALOX5 (0.49) ALOX5GGPS1TSHRMAPK1HSD17B10
SCHEMBL22888922 0.92 ALOX5 (0.47) ALOX5GGPS1TSHRMAPK1HSD17B10
SCHEMBL19397381 0.92 ALOX5 (0.55) ALOX5GGPS1TSHRMAPK1HSD17B10
SCHEMBL22888642 0.92 ALOX5 (0.43) ALOX5GGPS1TSHRMAPK1HSD17B10
SCHEMBL25047349 0.91 ALOX5 (0.48) ALOX5GGPS1PRKDCPIK3CDPIK3CB
SCHEMBL19397387 0.91 ALOX5 (0.48) ALOX5GGPS1TSHRMAPK1HSD17B10
SCHEMBL25050300 0.91 ALOX5 (0.51) ALOX5GGPS1TSHRPRKDCPIK3CD
SCHEMBL25050728 0.91 ALOX5 (0.50) ALOX5GGPS1PRKDCPIK3CDPIK3CB
SCHEMBL22888687 0.91 ALOX5 (0.50) ALOX5GGPS1TSHRPRKDCPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885GGPS1 3177/4885TSHR 1398/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885GGPS1 3231/4885TSHR 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.